2025
Impact of the International Tumor Budding Consensus Conference Recommendations in Oral Cancer
KOPECKA, Katerina; Michal HERMAN; Jaroslav MICHALEK; Jana ZAPLETALOVA; Markéta HERMANOVÁ et al.Základní údaje
Originální název
Impact of the International Tumor Budding Consensus Conference Recommendations in Oral Cancer
Autoři
KOPECKA, Katerina; Michal HERMAN; Jaroslav MICHALEK; Jana ZAPLETALOVA; Markéta HERMANOVÁ; Priska LIPTÁKOVÁ; Michal HENDRYCH; Michal MOZOLA a Richard PINK
Vydání
Oral diseases, Hoboken, Wiley, 2025, 1354-523X
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30109 Pathology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.900 v roce 2024
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/25:00140542
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
histopathology; oral squamous cell carcinoma; prognosis; tumor budding
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 10. 2025 13:48, Mgr. Tereza Miškechová
Anotace
V originále
ObjectivesTumor budding was suggested as a valuable prognostic factor in oral squamous cell carcinoma (OSCC) but lacks a standardized scoring system. This study evaluates tumor budding in OSCC using the scoring system recommended by the International Tumor Budding Consensus Conference (ITBCC) 2016.Materials and MethodsThe study included 114 patients with resected OSCC. Tumor budding was evaluated according to ITBCC criteria and assigned to three categories (low, intermediate, and high tumor budding). The associations between tumor budding and clinicopathological parameters were examined and survival rate analyses were performed by the Kaplan-Meier method. The prognostic value of tumor budding was assessed by Cox regression analysis.ResultsSignificant correlations of tumor budding with clinicopathological parameters including lymph node metastasis, grade, stage, perineural and lymphovascular invasion, and local recurrence were found. Intermediate and high tumor budding were significantly and independently associated with worse disease-free survival. High tumor budding was identified as an independent prognostic factor for disease-specific and overall survival.ConclusionsThe ITBCC scoring system represents a simple, feasible, and reproducible method to evaluate tumor budding in OSCC. Tumor budding, according to ITBCC criteria, showed its prognostic value in resected OSCC, and its incorporation into the histopathological reporting guidelines should be considered.